Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Direct Oral Anticoagulants: A User's Guide | Consultant360
Anticoagulants | Health Navigator NZ
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Rivaroxaban: a fully-subsidised oral anticoagulant
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
![PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3bd71fdf61b8f8bdc9321c5d380254016ae03ea/20-Table1-1.png "PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar")
PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Transition of Anticoagulants 2016
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
Guidance on Converting Between Anticoagulants
Xarelto® - Responsible Use
Transitioning Between Anticoagulants Continuous Infusion Unfractionated Heparin (UFH) SC LMWH or Fondaparinux Rivaroxaban (Xarel
Updated Guidelines on Outpatient Anticoagulation | AAFP
